Drawing for MARIGOLD THERAPEUTICS

USPTO serial 79460406

MARIGOLD THERAPEUTICS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with MARIGOLD THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Medicines for human purposes; pharmaceutical preparations for suppressing tumors; immunostimulants; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations and substances for the treatment of metabolic diseases and disorders.ACTIVE—
035Provision of an online marketplace for buyers and sellers of goods and services; procurement services for others [purchasing goods and services for other businesses]; sales promotion for others; retail services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail or wholesale services for medicines; retail or wholesale services for pharmaceutical preparations.ACTIVE—
042Technological research; conducting technical project studies; research and development of new products for others; research and development services in the field of antibodies; research and development of pharmaceutical preparations for treating malignant tumours; research and development services in the field of immunology; clinical trials; medical research; culturing of cells for scientific research purposes; scientific research in the field of genetics.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 5, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 20, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 20, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 15, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance